“We’re changing the paradigm for research,” said Josh Denny, M.D.,
All of Us’s chief executive officer. “Participants are our most important partners in this effort, and we know many of them are eager to get their genetic results and learn about the science they’re making possible. We’re working to provide that valuable information in a responsible way.”
The program’s in-depth genetic analyses include both whole genome sequencing and genotyping. Whole genome sequencing focuses on the more than 3 billion base pairs in the human genome, while genotyping looks at millions of genetic variants focused on people’s most common genetic differences.
MedCity News
Getting the right data to doctors is next hurdle for precision medicine
The future of precision medicine will come only as quickly as doctors can pick out clinically useful information from the genetic data being gathered on their patients.
Shares0
The science is getting sharper and the barriers to reimbursement are eroding. But another major obstacle remains to delivering on the promise of precision medicine.
It involves getting the right information into the hands of front-line doctors in a way that they can use it, experts and entrepreneurs in the field said in a series of interviews with MedCity News.
All of Us Precision Medicine Program Returns First Genetic Results healthitanalytics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthitanalytics.com Daily Mail and Mail on Sunday newspapers.